Co-Diagnostics, Inc.
corporate_fare Company Profile
Co-Diagnostics, Inc. (NASDAQ:CODX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 36 items for CODX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CODX spans 8-K, 10-Q, S-3, DEF 14A.
Recent high-impact activity:
- Co-Diagnostics Draws Second $1M J.J. Astor Tranche at 1.35x Factor, Netting $960K
- Co-Diagnostics Sets 1-for-25 Reverse Split Effective Nov. 24 to Chase Nasdaq $1.00 Bid
- Co-Diagnostics Holders Approve Reverse-Split Authority, Warrant Exercise and 2M-Share Plan Increase
- Co-Diagnostics Q3: Cash Falls to $715K, Going Concern Reaffirmed, J.J. Astor Loan Sweeps ATM Proceeds
- Co-Diagnostics Posts $1.01 Per-Share Q3 Loss as Cash Crunch Deepens
Financial Snapshot
Short Interest & Short Volume
2.24 days to coverFINRA reported short interest of 981,329 shares in CODX as of the October 30, 2026 settlement, a 49.5% increase from the prior period — about 2.2 days to cover at its recent average daily volume. On November 20, 2026, 56.3% of CODX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for CODX, detected from its recent SEC filings · based on capital-structure filings through 2026-11-04.
ATM Program Activated · Dilution Overhang
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →